Rhythm (Nasdaq: IRTC) today announced findings from a study of its Zio long-term continuous monitoring (LTCM) service.

GE HealthCare (Nasdaq: GEHC) today announced the launch of Vivid Pioneer, its newest, most advanced cardiovascular ultrasound system.

Cook Medical announced that it enrolled the final patient in the global clinical study of its Zenith Fenestrated+ Endovascular Graft (ZFEN+).

Picard Medical, the company behind the SynCardia Total Artificial Heart (TAH), announced a $17 million initial public offering (IPO).

A U.S. District Court judge denied a Johnson & Johnson MedTech unit's motion to renew judgment in its catheter-related antitrust case.

Abbott (NYSE: ABT) announced today that it received CE mark for an expanded indication for its Navitor TAVI system.

GE HealthCare (Nasdaq: GEHC) today unveiled its latest suite of cardiology innovations for improving workflows.

At DeviceTalks West Oct. 15-16, 2025, in Santa Clara, California, Abbott Neuromodulations’s Yagna Pathak, PhD, will sit on a panel exploring the clinical applications of connected health. Additionally ...

The FDA alerted customers to a letter from J&J MedTech's Abiomed instructing them to remove certain automated Impella.

Medtronic (NYSE: MDT) announced today that it received FDA approval for the expanded redo-TAVR indication of its Evolut system.

Zimmer Biomet (NYSE: ZBH) today announced the appointments of two doctors to separate chief medical advisor roles.

Bioretec announced today that it appointed Sarah van Hellenberg Hubar-Fisher as its new CEO, effective immediately.